Verrica announces positive results for molluscum contagiosum treatment

The treatment would help to address unmet medical needs against serious skin lesions Reports suggest that the lead candidate of Verrica Pharmaceuticals, a drug-device combination for dermatology indication, has achieved primary endpoints i....

Hua Medicine confirms patient enrollment for study of diabetes drug

Shanghai-based drug development firm Hua Medicine, which focuses on developing global first-in-class oral drug for treating Type 2 diabetes, has recently announced that it has completed patient enrollment for a Phase III monotherapy trial o....

Emergent BioSolutions to supply medical countermeasures to US

The company would manufacture and deliver several medical countermeasures prescribed by the Department of State including auto-injector training devices, Reactive Skin Decontamination Lotion Kit, and the Trobigard auto-injector Emergent Bi....

OneWeb inks two deals to deliver high speed communications services

The announcement was made the company at Mobile World Congress 2019 which is being held in Barcelona The company has signed two separate contracts with OneWeb and Intermatica The U.S. based satellite communications firm OneWeb has repo....

Atara Biotherapeutics to present clinical results of Car T platform

The firm is looking forward to its MSK collaborators’ clinical outcomes of a mesothelin-targeted autologous CAR T for patients suffering from advanced malignant pleural ailment   The event is slated to be held from March 29 t....

GNA & Boehringer collaborate on ASF diagnostic test development

Both the companies will come up with holistic solutions for farmers, veterinarians, and the food producing industry. The partnership aims to develop a diagnostic test for ASF. Research-driven pharma conglomerate Boehringer Ingelheim ha....

Sarepta to buy Myonexus to expand muscular dystrophy therapy portfolio

Sarepta Therapeutics has recently confirmed that it is planning to acquire Myonexus Therapeutics in a $165 million deal, by exercising a purchase option that was part of a gene therapy partnership commenced by the firms in the previous year....

Scholar Rock’s Phase 1 study of SRK-015 delivers positive interim data

Scholar Rock Holding Corporation, the clinical-stage biopharma company focusing on treating serious diseases which are affected by protein growth factors, has recently confirmed positive interim results for its Phase 1 multiple and single-a....

Ocutrx develops advanced Oculenz AR glasses with eye-tracking ability

California-based augmented reality (AR) glasses manufacturer, Ocutrx Vision Technologies, LLC, has recently unveiled its new, cutting-edge design for Oculenz™ AR Wear glasses, which is the company’s flagship product. Sources wi....

ZEDEDA announces close of $16 million Series A funding round

The funding is to support the company’s vision of creating an ultra-secure, open-source and standards-based cloud-native edge. ZEDEDA, one of the leaders in edge virtualization software announced that the company has recently secured....